Repeated brain tumor sampling uncovers treatment response in patients with glioblastoma

A multi-institutional study from the Accelerating GBM Therapies Through Serial Biopsies TeamLab, led by investigators from the Mass General Brigham Cancer Institute, found that serially testing tumor samples can help detect when a cancer treatment is activating the immune system in recurrent glioblastoma (GBM), even when traditional imaging measures cannot.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup